Viewing Study NCT01150357


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-05 @ 6:05 PM
Study NCT ID: NCT01150357
Status: COMPLETED
Last Update Posted: 2015-10-15
First Post: 2010-06-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pediatric hypertension View
None primary hypertension View
None secondary hypertension View